Drug-induced enterocolitis syndrome (DIES): A clinical entity that deserves more awareness

Ann Allergy Asthma Immunol. 2019 May;122(5):538-539. doi: 10.1016/j.anai.2019.02.004. Epub 2019 Feb 14.

Authors

Anders O J Van Thuijl¹, Lonneke J Landzaat², Olivia Liem², Joyce A M Emons², Nicolette J T Arends²

Affiliations

¹ Reinier de Graaf Gasthuis, Department of Pediatric Allergology, Delft, The Netherlands.
² Erasmus MC University Medical Center, Department of Pediatrics, Division of Respiratory Medicine and Allergology, Rotterdam, The Netherlands.

PMID: 30772389
DOI: 10.1016/j.anai.2019.02.004

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Amoxicillin / adverse effects*
Anti-Bacterial Agents / adverse effects*
Child, Preschool
Drug Hypersensitivity Syndrome / diagnosis
Drug Hypersensitivity Syndrome / immunology
Drug Hypersensitivity Syndrome / physiopathology*
Enterocolitis / chemically induced
Enterocolitis / diagnosis
Enterocolitis / immunology
Enterocolitis / physiopathology*
Humans
Male
Rare Diseases

Substances

Anti-Bacterial Agents
Amoxicillin